Investment is the dedication of an asset to attain an increase in value over a period of time. Investment requires a sacrifice of some present asset, such as time, money, or effort.
In finance, the purpose of investing is to generate a return from the invested asset. The return may consist of a gain (profit) or a loss realized from the sale of a property or an investment, unrealized capital appreciation (or depreciation), or investment income such as dividends, interest, or rental income, or a combination of capital gain and income. The return may also include currency gains or losses due to changes in the foreign currency exchange rates.
Investors generally expect higher returns from riskier investments. When a low-risk investment is made, the return is also generally low. Similarly, high risk comes with a chance of high returns.
Investors, particularly novices, are often advised to diversify their portfolio. Diversification has the statistical effect of reducing overall risk. investor may bear a risk of loss of some or all of their capital invested. Investment differs from arbitrage, in which profit is generated without investing capital or bearing risk.
Savings bear the (normally remote) risk that the financial provider may default.
Foreign currency savings also bear foreign exchange risk: if the currency of a savings account differs from the account holder's home currency, then there is the risk that the exchange rate between the two currencies will move so that the value of the savings account decreases, measured in the account holder's home currency.
Even investing in tangible assets like property has its risk. And just like with most risk, property buyers can seek to mitigate any potential risk by taking out and by borrowing at a lower loan to security ratio.
In contrast with savings, investments tend to carry more risk, in the form of both a wider variety of risk factors and a greater level of uncertainty.
Industry to industry volatility is more or less of a depending. In biotechnology, for example, investors look for big profits on companies that have small market but can be worth hundreds of millions quite quickly.[1] The risk is high because approximately 90% of biotechnology products researched do not make it to market due to regulations and the complex demands within pharmacology as the average prescription drug takes 10 years and US$2.5 billion worth of capital.[2]Free cash flow measures the cash a company generates which is available to its debt and equity investors, after allowing for reinvestment in working capital and capital expenditure. High and rising free cash flow, therefore, tend to make a company more attractive to investors.
The debt-to-equity ratio is an indicator of capital structure. A high proportion of debt, reflected in a high debt-to-equity ratio, tends to make a company's earnings, free cash flow, and ultimately the returns to its investors, riskier or volatile. Investors compare a company's debt-to-equity ratio with those of other companies in the same industry, and examine trends in debt-to-equity ratios and free cashflow.
See also
Edit
Asset
Capital accumulation
Capital gains tax
Climate-related asset stranding
Diversification (finance)
EBITDA
Financial risk
Foreign direct investment
Fundamental analysis
Fundamental Analysis Software
Hedge fund
List of countries by gross fixed investment as percentage of GDP
List of economics topics
Market sentiment
Mortgage investment corporation
Rate of return
Socially responsible investing
Specialized investment fund
Time value of money
Time-weighted return
Mutual Fund
Great
You must be logged in to post a comment.